Regulatory Issues Concerning the Safety, Efficacy and Quality of Herbal Remedies

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 68, Issue 6, 2003, Pages 505-510

  Rousseaux, Colin G ^a   Schachter, Howard ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Efficacy; Fetal effects, Safety; Herbal remedies; Quality; Regulation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BELLADONNA ALKALOID; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID; CANNABIS; COLESTIPOL; COLESTYRAMINE; COUMARIN; CYTOCHROME P450 3A4; DIAZEPAM; DICOUMAROL; DIGITALIS; DIGOXIN; DRUG METABOLIZING ENZYME; FLUOXETINE; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; LAXATIVE; NARCOTIC AGENT; OPIATE; PAROXETINE; PENICILLIN G; PHYTOESTROGEN; PLANT EXTRACT; PYRROLIZIDINE ALKALOID; SCOPOLAMINE; SUCRALFATE; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; CHRONIC DRUG ADMINISTRATION; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; DRUG INFORMATION; DRUG INTERACTION; DRUG LABELING; DRUG MANUFACTURE; DRUG MARKETING; DRUG PURITY; DRUG QUALITY; DRUG SAFETY; DRUG SCREENING; EMBRYOTOXICITY; ENDOCRINE DISEASE; FETUS DEVELOPMENT; FOOD AND DRUG ADMINISTRATION; HERBAL MEDICINE; HUMAN; HYPERESTROGENISM; HYPERICUM PERFORATUM; LAW; LIVER CIRRHOSIS; LIVER NECROSIS; LIVER TOXICITY; MENOPAUSAL SYNDROME; PREGNANCY; PRIORITY JOURNAL; REVIEW; TERATOGENICITY; VEIN OCCLUSION;

FEMALE; HUMANS; MATERNAL EXPOSURE; MEDICINE, HERBAL; MEDICINE, TRADITIONAL; MODELS, BIOLOGICAL; PLANT EXTRACTS; PLANT PREPARATIONS; PLANTS, MEDICINAL; PREGNANCY; TERATOGENS;

EID: 0347357905     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.10053     Document Type: Review

References (26)

1. Angell M, Kassirer JP. 1998. Alternative medicines-the risks of untested and unregulated remedies. Editorial. N Engl J Med 339:839-841.
2. Arase Y. 1997. The long-term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79:1494-1500.
3. Bensky D, Gamble A, Kaptchuk TJ. 1986. Chinese herbal medicine: materia medica. Seattle, WA: Eastland Press.
4. Bensky D, Barolet R. 1990. Chinese herbal medicine: formulas and strategies. Seattle, WA: Eastland Press.
5. Bratman S, Kroll DJ, DePalma A. 2000. The natural pharmacist: natural health bible, 2nd Ed. Rocklin: Prima Publishing.
6. Consumer Reports. 1995. Herbal roulette. Yonkers, NY: Consumers Union Press, p 698.
7. Devine N. 2000. Dangerous combinations; understanding the risks of mixing herbal products and drugs. Nurse Week 13:26.
8. DiPaola RS, Zhang H, Lambert GH. 1998. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339:785-791.
9. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, VanRompay M, Kessler RC. 1998. Trends in alternative medicine prevalence and costs 1990-1997: results of a follow-up national survey. J Am Med Assoc 280:1569-1575.
10. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. 1993. Unconventional medicine in the United States-prevalence, costs and patterns of use. N Engl J Med 328:246-252.
11. Joy JE, Watson SJ Jr, Benson JA Jr. 1999. Marijuana and medicine: assessing the science base. Institute of Medicine. Washington, D.C.: National Academy of Sciences. p 1-288.
12. Kliewer SA, Lehmann JM, Wilson TM. 1999. Orphan nuclear receptors: shifting endocrinology into reverse. Science 284:757-760.
13. Ko RJ. 1998. Adulterants in Asian patent medicines. N Engl J Med 339:847.
14. Lock M. 1991. Contested meanings of the menopause. Lancet 337:1270-1272.
15. Lüthy J, Zweifel U, Schmid P. 1983. Pyrrolizidine alkaloids in Petasites hybridus L. and P. albus L. Pharm Acta Helv 58:98-100.
16. Marderosian AD, Liberti LE. 1988. Natural product medicine. Philadelphia: George F. Stickley Co. p 87-150.
17. Mauz C, Candrian U, Lüthy J. 1985. Method for the reduction of pyrrolizidine alkaloids from medicinal plant extracts. Pharm Acta Helv 60:256-259.
18. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Wilson TM. 2000. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500-7502.
19. Nies AS, Spielberg SE 1996. Principles of therapeutics. In: Hardman JG, Lumbard LE, Molenoff PB, Ruddon RW, Gilman AG, editors. The pharmacological basis of therapeutics. 9th Ed. New York: McGraw-Hill. p 43-62.
20. Page RL II, Lawrence JD. 1999. Potentiation of warfarin by dong quai. Pharmacotherapy 19:870-876.
21. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM. 1999. Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365-1368.
22. Samuelsson G. 1992. Drugs of natural origin: a textbook of pharmacognosy. Sweden: Swedish Pharmaceutical Press.
23. Slifman NR, Obermeyer WR, Aloi BK. 1998. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 339:806-811.
24. Studdert DM, Eisenberg DM, Miller FH, Curto DA, Kaptchuk TJ, Brennan TA. 1998. Medical malpractice implications of alternative medicine. J Am Med Assoc 280:1610-1615.
25. United Nations Single Convention on Narcotic Drugs, Article 31, 1961. New York, NY: United Nations Publications.
26. U.S. Food and Drug Administration. 1993. Center for Food Safety and Applied Nutrition. Illnesses and injuries associated with the use of selected dietary supplements. FDA Consumer.